A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence
Public ClinicalTrials.gov record NCT01354470. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The proposed study will establish the safety and efficacy of modafinil in the treatment of methamphetamine dependence, as well as assess the affects of modafinil on cognitive function in methamphetamine users and on methamphetamine withdrawal symptoms. In this outpatient trial, methamphetamine- dependent, treatment-seeking subjects will receive modafinil or placebo daily for four weeks, along with weekly Motivational Enhancement Therapy sessions. This study will be conducted at the Addiction \& Pharmacology Laboratory in San Francisco, CA, and at the New Leaf Treatment Center in Lafayette, CA, and is expected to last one year.
Study identification
- NCT ID
- NCT01354470
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2011
- Primary completion
- Jan 31, 2013
- Completion
- Not listed
- Last update posted
- Jul 1, 2013
Started 2011
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| New Leaf Treatment Center | Lafayette | California | 94549 | — |
| CPMC Research Institute, St.Luke's Hospital | San Francisco | California | 94110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Methamphetamine Dependence trials
Other public records listing Methamphetamine Dependence. Sorted by last update posted; newest first. Not a recommendation.
- NCT07204249: Glutide for Ending Methamphetamine Recruiting
- NCT06233799: Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder Recruiting
- NCT04927143: Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives Recruiting
- NCT06027814: MHealth Incentivized Adherence Plus Patient Navigation Active, not recruiting
- NCT04317482: The Human Stress Response in a Simulated ED Setting Active, not recruiting
- NCT05162391: Inflammation in Methamphetamine and STIs (IMSTI) Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01354470, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2013 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01354470 live on ClinicalTrials.gov.